Pilot Projects 2015-2016

Jose Aleman, MD, PhD
Breslow Laboratory

Mechanisms of accelerated atherosclerosis in brown adipose tissue expansion


Tali Czarnowicki, MD
Krueger Laboratory

Phenotype, regulation and development of the immune system in adult atopic dermatitis patients


Oyebisi Jegede, MBBS, PhD
Rice Laboratory

Effects of chronic viral infection on immune response to Zoster vaccination


Gadi Lalazar, MD
Simon Laboratory

Phosphoproteomics of Fibrolamellar Hepatocellular Carcinoma


Avi Levin, MD
Steller Laboratory

Colon cancer-associated proteasomal assembly is a potential novel therapeutic target


Isaac Marin-Valencia
Gleeson Laboratory

Expanding diagnostic and therapeutic approaches for inherited brain metabolic disorders by exome analysis


Claudio Alarcon
Tavazoie Laboratory

Identifying factors that regulate the cross-talk between metastatic pancreatic cells and the immune system


Ursula Andreo, PhD
Rice Laboratory

The impact of metabolic syndrome on the antiviral immune response


Ype de Jong, MD, PhD
Rice Laboratory

Programmed bacteria to coordinately deliver antitumor therapeutics in hepatocellular carcinoma xenografts


Benjamin Farber, MD
Simon Laboratory

Using Non-coding RNAs as a Diagnostic tool in Fibrolamellar Hepatocellular Carcinoma


Paul Muller
Mucida Laboratory



Lily Nguyen, MS
Cohen Laboratory

The role of adipose tissue in bariatric surgery


Virginia Pedicord
Hang Laboratory

Identifying beneficial gut bacteria mechanisms for the rational design of probiotics against intestinal infections


Kareem Rumah
Fischetti Lab

Identification of Clostridium perfringens enterotoxin as a novel candidate trigger for Sudden Infant Death Syndrome


Sameer Sharma
Steller Laboratory

“COCOON” – A Novel Intestinal Protective Agent


Jeanne Walker, MSN,NP-C
Rockefeller University Center for Clinical and Translational Science
JWA-0786 Pilot Study: The effects of trans-resveratrol (RSV) on insulin resistance, inflammation and the metabolic syndrome: A placebo controlled double-blind study.


Ethan Weinberg, MD
Tavazoie Laboratory
Phosphoenolpyruvate carboxykinase 1 (PCK1) is a potential therapeutic target for metastatic colorectal cancer liver colonization


Yuehyi Gloria Wu
Tavazoie Laboratory

Identifying and Characterizing Metastasis Regulators as Novel Therapeutic Targets for the Treatment of Pancreatic Adenocarcinoma

Jose Aleman, MD, PhDBreslow LaboratoryMechanisms of accelerated atherosclerosis in brown adipose tissue expansion Tali Czarnowicki, MDKrueger LaboratoryPhenotype, regulation and development o